(Q40321343)

English

Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis

scientific article published on 17 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

West Nile virus

0 references

Philippe Desprès

5

object named as

Philippe Desprès

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Marie-Pascale Frenkiel

2

object named as

Marie-Pascale Frenkiel

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xavier Montagutelli

3

object named as

Xavier Montagutelli

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dominique Simon-Chazottes

1

object named as

Dominique Simon-Chazottes

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Jean-Louis Guénet

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jean-Jacques Panthier

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

17 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

417

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

147-153

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

SARs do not impair position-dependent expression of a kit/lacZ transgene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

The host immunologic response to West Nile encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Expression of the gene of interest fused to the EGFP-expressing gene in transgenic mice derived from selected transgenic embryos

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Detection of West Nile virus lineages 1 and 2 by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Introduction of West Nile virus in the Middle East by migrating white storks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2',5'-oligoadenylate synthetases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Chapter 9. Studying nonsense-mediated mRNA decay in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

'Green mice' as a source of ubiquitous green cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Positional cloning of the murine flavivirus resistance gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Knock-in of the Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Differential Expression of Interferon (IFN) Regulatory Factors and IFN-Stimulated Genes at Early Times after West Nile Virus Infection of Mouse Embryo Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Optimization of transcriptional regulatory elements for constructing plasmid vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

On the subspecific origin of the laboratory mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.018

7 January 2021

Identifiers

10.1016/J.VIROL.2011.05.018

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

release_j7azzzj3bfdsdaesfqgvlzzxhu

1 reference

https://api.fatcat.wiki/v0/release/j7azzzj3bfdsdaesfqgvlzzxhu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40321343&oldid=1895069981"